Is Teladoc Health stock a good buy?
Teladoc Health, Inc. (NYSE:TDOC) delivered a -39.02% return since the beginning of the year, while its 12-month returns are down by -67.23%. The stock closed at $55.99 per share on April 25, 2022. "Teladoc is the largest telehealth provider in the US and has recently begun to expand internationally.
Who is Teladoc biggest competitor?
AmwellAmwell (NYSE: AMWL), formerly known as American Well, is a telemedicine company founded in 2006 and went public in 2020. It is currently the biggest competitor to Teladoc in the telehealth space and has experienced significant growth in recent years.
Will Teladoc ever recover?
Despite the stock's steady decline over the past year, Teladoc Health still holds a promising future due to its disruptive model. According to Tulane University School of Public Health and Tropical Medicine, Telemedicine is here to stay for the foreseeable future.
Is Teladoc overvalued?
Valuation metrics show that Teladoc Health, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of TDOC, demonstrate its potential to underperform the market.
Who is the biggest telemedicine company?
Teladoc HealthTeladoc Health is the largest telemedicine provider, with $1.09 billion in revenue and over 1,800 employees.
What company owns Teladoc?
The Vanguard Group, Inc. Baillie Gifford & Co. Nikko Asset Management Co., Ltd.
Is teladoc undervalued?
The revenue per member was reported $2.32 in 2021, up from $1.12 in 2020. I believe Teladoc's stock price is undervalued based on relative valuation indicators. The stock's price-to-sales ratio hit below 4 in mid-March (lowest since 2016) and is trading at 5.33, while the price-to-book ratio is at 0.69.
Is Teladoc a profitable company?
Despite the company's strong financial performance, Teladoc's shares plummeted 54% in 2021, compared to the S&P 500's strong gain of approximately 27%. The telehealth giant isn't yet profitable and reported a loss of $84.3 million in the third quarter of 2021, deeper than its year-prior loss of $36 million.
Is teladoc a good company?
The employee experience below at Teladoc Health (formerly Livongo), compared to a typical company. 84% of employees at Teladoc Health (formerly Livongo) say it is a great place to work compared to 57% of employees at a typical U.S.-based company. Source: Great Place to Work® 2021 Global Employee Engagement Study.
Is Tdoc a Buy Sell or Hold?
Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 8 buy ratings, 18 hold ratings, and no sell ratings.
What is the target price for teladoc?
Stock Price Target TDOCHigh$141.00Median$43.50Low$30.00Average$50.29Current Price$34.53
How does Tdoc make money?
Teladoc makes money by offering a subscription-based model. Clients (employers) pay annual or monthly subscriptions for access to Teladoc's varying services and offer these to employees.
NYSE: TDOC
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
What happened
Shares of Teladoc Health ( TDOC -4.79% ) were falling 3.2% as of 2:42 p.m. ET on Wednesday. The decline appeared to be linked to reduced concerns about the impact of the coronavirus omicron variant.
So what
It's understandable why investors would be less bullish about Teladoc over the near term, with omicron-variant fears easing. The healthcare stock would almost certainly be a winner if more people turned to virtual care with a worsening pandemic.
Now what
The omicron variant could still prove to be a tailwind for Teladoc over the next few months. However, the company also has other growth drivers on the way, notably including a major contract with the nation's fifth-largest health insurer HCSC, which goes into effect in January.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
What was Teladoc's loss in the first quarter?
Finally, Teladoc fell again after its first-quarter earnings report in late April as the company posted a wide GAAP loss per share of $1.31, which was worse than the consensus at a loss of $0.62.
Is Teladoc open to Amazon?
In March, Teladoc slumped again on news that Amazon ( NASDAQ:AMZN) was expanding its Amazon Care telehealth pilot program, saying it will be open to Amazon employees and companies in all 50 states, competing more directly with Teladoc.
NYSE: TDOC
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
What happened
Shares of virtual healthcare provider Teladoc Health ( TDOC -1.03% ) fell 54% last year, according to data provided by S&P Global Market Intelligence. The performance is especially painful in a year in which the S&P 500 index climbed nearly 30%. The primary concern is growth.
So what
Teladoc grew U.S. subscription members 41% in 2020. That was thanks mostly to the onset of the coronavirus and aided by its acquisition of Livongo, a digital chronic care management company. CEO Jason Gorevic knew 2020 would be a tough act to follow since so many deals were pulled forward during the pandemic. And he was right.
NYSE: TDOC
Teladoc's market capitalization was cut in half through 2021 and is down to $13.2 billion. That's a 70% collapse from its peak in February. Further, the company's value as a multiple of gross profit is at a multiyear low; the ratio bottomed at 12 during pullbacks in 2018 and 2019.
Now what
What might derail it? For one, competition is heating up. And not just from the usual suspects like Amwell or Doximity. Unitedhealth Group ( UNH 0.17% ) -- the largest health insurer in the U.S. -- recently launched its own virtual-first health plan called NavigateNOW.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
What Happened to the Teladoc Stock Price Today?
Teladoc (NASDAQ: TDOC) stock dropped nearly 10% after the telehealth provider reported first-quarter numbers, beating top- and bottom-line expectations.
Meet Luke Lango
By uncovering early investments in hypergrowth industries, Luke Lango puts you on the ground-floor of world-changing megatrends.
Teladoc: Leader in Virtual Care
Virtual healthcare exploded during the pandemic out of necessity. Patients and doctors were able to connect virtually and solve many health issues, in both physical and mental health. The Teladoc platform experienced a 38x increase in volumes during this time, according to the company.
Massive Gains, but Profitability Less
Teladoc was growing modestly prior to the pandemic, having gained 32% to $553 million in fiscal 2019. Then, in 2020, revenue mushroomed to $1.1 billion, a 97% increase. Even better, 2021 revenues are expected to grow another 85% to $2 billion. The concerning news is that 2022 growth is expected to slow to a modest 28%.
Teladoc Takeaway
There is no doubt that virtual healthcare is here to stay. The convenience, cost savings, and health considerations guarantee that patients and healthcare providers will continue to take advantage of it. Teladoc is a leader in this field and has used the pandemic tailwinds to massively increase revenues.
TipRanks
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.